Covered recipient · General Payments record
AUSTIN LORENZO OFRENEO
Eye and Vision Services Providers Optometrist
General Payments · PY2019–2024
$923.50
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $543.94 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CooperVision Inc. | $243.31 | 5 |
| Alcon Laboratories Inc | $175.62 | 12 |
| Tarsus Pharmaceuticals, Inc. | $125.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alcon Vision LLC | $13.86 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700446 | CMS |
| Alcon Vision LLC | $22.23 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700458 | CMS |
| Alcon Vision LLC | $18.60 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700450 | CMS |
| Alcon Vision LLC | $17.10 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700448 | CMS |
| Alcon Vision LLC | $12.69 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700442 | CMS |
| Alcon Vision LLC | $19.21 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700454 | CMS |
| Alcon Vision LLC | $8.21 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700440 | CMS |
| Alcon Vision LLC | $13.39 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700444 | CMS |
| Alcon Vision LLC | $6.40 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700438 | CMS |
| Alcon Vision LLC | $18.60 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700452 | CMS |
| Alcon Vision LLC | $4.84 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700436 | CMS |
| Alcon Vision LLC | $20.49 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700456 | CMS |
| CooperVision Inc. | $51.00 | 03/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145522852 | CMS |
| CooperVision Inc. | $18.32 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145522846 | CMS |
| CooperVision Inc. | $130.00 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145522870 | CMS |
| CooperVision Inc. | $22.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145522856 | CMS |
| CooperVision Inc. | $21.99 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145522892 | CMS |
| Tarsus Pharmaceuticals, Inc. | $125.01 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139121466 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.